Enhancing Heart Allograft Function With the OCS Heart System Trial
Start Date
1/1/2026
Completion Date
7/30/2027
Summary
This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
OCS Heart
Static Cold Storage (SCS)
Conditions
Locations
University of California San Francisco
San Francisco, California 94143
United States
Tampa General Hospital
Tampa, Florida 33606
United States
Massachusetts General Hospital
Boston, Massachusetts 02114
United States
Mount Sinai
New York, New York 10029
United States
Columbia University Irving Medical Center/ New York Presbyterian Hospital
New York, New York 10032
United States
Westchester Medical Center
Valhalla, New York 10595
United States
Duke University
Durham, North Carolina 27710
United States
Baylor Scott and White
Dallas, Texas 75226
United States